Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sertraline Versus Escitalopram in South Asian Participants With Moderate to Severe Major Depressive Disorder: A Double-blind, Parallel, Randomized Controlled Trial

NCT05950061 is registered in ClinicalTrials.gov with KRL Hospital, Islamabad as lead sponsor.

NCT NCT05950061
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05950061 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sertraline Versus Escitalopram in South Asian Participants With Moderate to Severe Major Depressive Disorder: A Double-blind, Parallel, Randomized Controlled Trial
Lead sponsor
KRL Hospital, Islamabad
Phase
Phase 3
Overall status
Completed
Start date
June 1, 2022
Completion date
February 26, 2023
Enrollment
744 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder